Literature DB >> 17661845

The public health impact of widespread availability of nonoccupational postexposure prophylaxis against HIV.

I M Poynten1, D E Smith, D A Cooper, J M Kaldor, A E Grulich.   

Abstract

OBJECTIVE: The aim of the study was to describe the use of nonoccupational postexposure prophylaxis (NPEP) in Australia, and to estimate the number of HIV infections that its use prevented.
METHODS: We conducted a population-based observational cohort study of people who presented to antiretroviral prescribers in Eastern Australia, and reported a high-risk nonoccupational exposure to HIV, in 1998-2004. Prescribers collected data at baseline, 4 weeks and 6 months. Data collected included details of HIV exposure, drug regimens and HIV serostatus.
RESULTS: The great majority of the 1601 participants were male (95%) and presented after male homosexual exposure (87%). Only 32% of exposures were to HIV-positive sources. Two antiretroviral drugs were prescribed after 48% of events, and three or more drugs after 52% of events. The median time to receipt of NPEP was 23 h. Side effects were reported by 66% of participants. No case of NPEP failure in an adherent individual was identified. It was estimated that 0.9-9.2 HIV infections had been prevented. This compared with a total of 1138 newly acquired HIV infections notified in the geographical area covered by the study.
CONCLUSIONS: In Australia, NPEP has been widely prescribed and is mainly targeted at high-risk exposures. Although there were no identified failures of NPEP, it is likely that only a small proportion of new HIV infections in the study area were prevented. NPEP may be a valuable preventive intervention for an individual, but it can only play a minor role in HIV prevention at the population level unless targeting can be further improved.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17661845     DOI: 10.1111/j.1468-1293.2007.00483.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  6 in total

1.  Non-occupational post-exposure prophylaxis for HIV: 10-year retrospective analysis in Seattle, Washington.

Authors:  Sarah J McDougal; Jeremiah Alexander; Shireesha Dhanireddy; Robert D Harrington; Joanne D Stekler
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

2.  Antiretrovirals to prevent HIV infection: pre- and postexposure prophylaxis.

Authors:  Cynthia L Gay; Myron S Cohen
Journal:  Curr Infect Dis Rep       Date:  2008-07       Impact factor: 3.725

Review 3.  AIDS vaccines and preexposure prophylaxis: is synergy possible?

Authors:  Jean-Louis Excler; Wasima Rida; Frances Priddy; Jill Gilmour; Adrian B McDermott; Anatoli Kamali; Omu Anzala; Gaudensia Mutua; Eduard J Sanders; Wayne Koff; Seth Berkley; Patricia Fast
Journal:  AIDS Res Hum Retroviruses       Date:  2010-12-16       Impact factor: 2.205

4.  Trends in condom use and risk behaviours after sexual exposure to HIV: a seven-year observational study.

Authors:  Enrique Casalino; Christophe Choquet; Agathe Leleu; Romain Hellmann; Mathias Wargon; Gaelle Juillien; Yazdan Yazdanpanah; Elisabeth Bouvet
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

5.  Pre-exposure and postexposure prophylaxes and the combination HIV prevention methods (The Combine! Study): protocol for a pragmatic clinical trial at public healthcare clinics in Brazil.

Authors:  Alexandre Grangeiro; Márcia Thereza Couto; Maria Fernanda Peres; Olinda Luiz; Eliana Miura Zucchi; Euclides Ayres de Castilho; Denize Lotufo Estevam; Rosa Alencar; Karina Wolffenbüttel; Maria Mercedes Escuder; Gabriela Calazans; Dulce Ferraz; Érico Arruda; Maria da Gloria Corrêa; Fabiana Rezende Amaral; Juliane Cardoso Villela Santos; Vivian Salles Alvarez; Tiago Kietzmann
Journal:  BMJ Open       Date:  2015-08-25       Impact factor: 2.692

6.  Expert consensus statement on the science of HIV in the context of criminal law.

Authors:  Françoise Barré-Sinoussi; Salim S Abdool Karim; Jan Albert; Linda-Gail Bekker; Chris Beyrer; Pedro Cahn; Alexandra Calmy; Beatriz Grinsztejn; Andrew Grulich; Adeeba Kamarulzaman; Nagalingeswaran Kumarasamy; Mona R Loutfy; Kamal M El Filali; Souleymane Mboup; Julio Sg Montaner; Paula Munderi; Vadim Pokrovsky; Anne-Mieke Vandamme; Benjamin Young; Peter Godfrey-Faussett
Journal:  J Int AIDS Soc       Date:  2018-07       Impact factor: 5.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.